AAAAAA

   
Results: 1-7 |
Results: 7
LESSONS FOR AIDS VACCINE DEVELOPMENT FROM NON-AIDS VACCINES
Authors: CLEMENTSMANN ML
Citation: Ml. Clementsmann, LESSONS FOR AIDS VACCINE DEVELOPMENT FROM NON-AIDS VACCINES, AIDS research and human retroviruses, 14, 1998, pp. 197-203
NEUTRALIZATION OF SYNCYTIUM-INDUCING PRIMARY ISOLATES BY SERA FROM HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-UNINFECTED RECIPIENTS OF CANDIDATE HIV VACCINES
Authors: ZOLLAPAZNER S XU S BURDA S DULIEGE AM EXCLER JL CLEMENTSMANN ML
Citation: S. Zollapazner et al., NEUTRALIZATION OF SYNCYTIUM-INDUCING PRIMARY ISOLATES BY SERA FROM HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-UNINFECTED RECIPIENTS OF CANDIDATE HIV VACCINES, The Journal of infectious diseases, 178(5), 1998, pp. 1502-1506
IMMUNE-RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 INDUCEDBY CANARYPOX EXPRESSING HIV-1(MN) GP120, HIV-1(SF2) RECOMBINANT GP120, OR BOTH VACCINES IN SERONEGATIVE ADULTS
Authors: CLEMENTSMANN ML WEINHOLD K MATTHEWS TJ GRAHAM BS GORSE GJ KEEFER MC MCELRATH MJ HSIEH RH MESTECKY J ZOLLAPAZNER S MASCOLA J SCHWARTZ D SILICIANO R COREY L WRIGHT PF BELSHE R DOLIN R JACKSON S XU S FAST P WALKER MC STABLEIN D EXCLER JL TARTAGLIA J DULIEGE AM SINANGIL F PAOLETTI E
Citation: Ml. Clementsmann et al., IMMUNE-RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 INDUCEDBY CANARYPOX EXPRESSING HIV-1(MN) GP120, HIV-1(SF2) RECOMBINANT GP120, OR BOTH VACCINES IN SERONEGATIVE ADULTS, The Journal of infectious diseases, 177(5), 1998, pp. 1230-1246
SAFETY PROFILE OF PHASE-I AND PHASE-II PREVENTIVE HIV TYPE-1 ENVELOPEVACCINATION - EXPERIENCE OF THE NIAID AIDS VACCINE EVALUATION GROUP
Authors: KEEFER MC WOLFF M GORSE GJ GRAHAM BS COREY L CLEMENTSMANN ML VERANIKETTER N ERB S SMITH CM BELSHE RB WAGNER LJ MCELRATH MJ SCHWARTZ DH FAST P CHARRON K REYNOLDS MJ ZIMMERMAN E JONES K HARRIS M FREY SE KENNEDY DJ ISRAEL H BERRY C READ B SPITZ T PACATTE T DOLIN R REICHMAN RC LAMBERT J DEMETER L ROBERTS NJ PUGLIESE M BERGER D BURKE J SCOTT T BLACKSTONE E WRIGHT PF BRAEUNER M RYBCZYK GK CRUMBO K BATTLE W CORNELL R OWENS D JENNINGS M HARBISON MA HENSMAN BJ BARR P STABLEIN DM VOSS T PALLAS S LOMAX N KOFF W LAWRENCE D JOHNSTON M SAVARESE B WESCOTT SL
Citation: Mc. Keefer et al., SAFETY PROFILE OF PHASE-I AND PHASE-II PREVENTIVE HIV TYPE-1 ENVELOPEVACCINATION - EXPERIENCE OF THE NIAID AIDS VACCINE EVALUATION GROUP, AIDS research and human retroviruses, 13(14), 1997, pp. 1163-1177
RESPIRATORY SYNCYTIAL VIRUS (RSV) SH AND G-PROTEINS ARE NOT ESSENTIALFOR VIRAL REPLICATION IN-VITRO - CLINICAL-EVALUATION AND MOLECULAR CHARACTERIZATION OF A COLD-PASSAGED, ATTENUATED RSV SUBGROUP-B MUTANT
Authors: KARRON RA BUONAGURIO DA GEORGIU AF WHITEHEAD SS ADAMUS JE CLEMENTSMANN ML HARRIS DO RANDOLPH VB UDEM SA MURPHY BR SIDHU MS
Citation: Ra. Karron et al., RESPIRATORY SYNCYTIAL VIRUS (RSV) SH AND G-PROTEINS ARE NOT ESSENTIALFOR VIRAL REPLICATION IN-VITRO - CLINICAL-EVALUATION AND MOLECULAR CHARACTERIZATION OF A COLD-PASSAGED, ATTENUATED RSV SUBGROUP-B MUTANT, Proceedings of the National Academy of Sciences of the United Statesof America, 94(25), 1997, pp. 13961-13966
EVALUATION OF 2 LIVE, COLD-PASSAGED, TEMPERATURE-SENSITIVE RESPIRATORY SYNCYTIAL VIRUS-VACCINES IN CHIMPANZEES AND IN HUMAN ADULTS, INFANTS, AND CHILDREN
Authors: KARRON RA WRIGHT PF CROWE JE CLEMENTSMANN ML THOMPSON J MAKHENE M CASEY R MURPHY BR
Citation: Ra. Karron et al., EVALUATION OF 2 LIVE, COLD-PASSAGED, TEMPERATURE-SENSITIVE RESPIRATORY SYNCYTIAL VIRUS-VACCINES IN CHIMPANZEES AND IN HUMAN ADULTS, INFANTS, AND CHILDREN, The Journal of infectious diseases, 176(6), 1997, pp. 1428-1436
IMMUNOGENICITY OF 2 DOSES OF YEAST RECOMBINANT HEPATITIS-B VACCINE INHEALTHY OLDER ADULTS
Authors: GELLIN BG GREENBERG RN HART RH BERTINO JS STEIN DH DELORIA MA CLEMENTSMANN ML
Citation: Bg. Gellin et al., IMMUNOGENICITY OF 2 DOSES OF YEAST RECOMBINANT HEPATITIS-B VACCINE INHEALTHY OLDER ADULTS, The Journal of infectious diseases, 175(6), 1997, pp. 1494-1497
Risultati: 1-7 |